Scarica l'app Stockscreener
0.8425
1.49%
0.0124
Gossamer Bio Inc Borsa (GOSS) Ultime notizie
Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1? - Insider Monkey
11 Best Penny Stocks to Invest in Under $1 - Insider Monkey
Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple - Insider Monkey
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple - Yahoo Finance
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 - BioSpace
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rul - GuruFocus
Gossamer Bio Announces Inducement Grant Under - MarketScreener
10 Stocks Under $10 that Will Triple - Insider Monkey
Hypertension Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
Charles Schwab Investment Management Inc. Raises Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch? - MSN
Cantor Fitzgerald Comments on Gossamer Bio FY2025 Earnings - Defense World
Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5? - Insider Monkey
Gossamer Bio Inc (NASDAQ: GOSS) Analysts Think Could Fell -290.62% From Current Levels - Stocks Register
Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts - Yahoo Finance
Gossamer Bio, Inc. (NASDAQ:GOSS) Position Decreased by Victory Capital Management Inc. - Defense World
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
10 Hot Biotech Stocks Under $5 - Insider Monkey
Q1 EPS Estimates for Gossamer Bio Reduced by HC Wainwright - Defense World
FY2028 EPS Forecast for Gossamer Bio Decreased by Analyst - Defense World
GOSSAMER BIO Earnings Preview: Recent $GOSS Insider Trading, Hedge Fund Activity, and More - Nasdaq
H.C. Wainwright maintains Buy on Gossamer Bio, $10 target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Gossamer Bio, $10 target - Investing.com
Wedbush Reiterates Outperform Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World
Gossamer Bio Reports 2024 Financial Results and Progress - TipRanks
Gossamer Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa
Gossamer Bio shares rise on Q4 earnings beat - Investing.com India
Gossamer Bio Inc (GOSS) Q4 Earnings: EPS Loss of $0.15 Beats Est - GuruFocus.com
Gossamer Bio: Q4 Earnings Snapshot - mySA
Gossamer Bio earnings beat by $0.02, revenue topped estimates - Investing.com UK
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - The Bakersfield Californian
3 Promising Penny Stocks With Over $100M Market Cap - Simply Wall St
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) -March 07, 2025 at 05:47 pm EST - Marketscreener.com
Can Gossamer Bio's Latest Stock Options Package Attract Top Talent in Biotech? - Stock Titan
With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners - Yahoo Finance
Gossamer Bio (GOSS) Projected to Post Quarterly Earnings on Tuesday - Defense World
You Should Read This Analysis Before Investing in Gossamer Bio Inc (NASDAQ:GOSS) - US Post News
Gossamer Bio Inc (NASDAQ: GOSS) Up 11.11% This Year: What Is Going To Happen Next - Stocks Register
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):